Pathogenesis	NN
pathways	NNS
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
in	IN
bleomycin-induced	JJ
lung	NN
injury	NN
model	NN
in	IN
mice	NNS
.	.

Our	PRP$
objective	NN
was	VBD
to	TO
investigate	VB
the	DT
pathogenesis	NN
pathways	NNS
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
.	.

Bleomycin	NN
(	(
BLM	NN
)	)
induced	VBD
animal	NN
models	NNS
of	IN
experimental	JJ
lung	NN
fibrosis	NN
were	VBD
used	VBN
.	.

CHIP	NN
assay	NN
was	VBD
executed	VBN
to	TO
find	VB
the	DT
link	NN
between	IN
Smad3	NN
and	CC
IL-31	NN
,	,
and	CC
the	DT
expressions	NNS
of	IN
TGF-b1	NN
,	,
Smad3	NN
,	,
IL-31	NN
and	CC
STAT1	NN
were	VBD
detected	VBN
to	TO
find	VB
whether	IN
they	PRP
were	VBD
similar	JJ
with	IN
each	DT
other	JJ
.	.

We	PRP
found	VBD
that	IN
in	IN
the	DT
early	JJ
injury	NN
or	CC
inflammation	NN
of	IN
the	DT
animal	NN
model	NN
,	,
BLM	NNP
promoted	VBD
the	DT
development	NN
of	IN
inflammation	NN
,	,
leading	VBG
to	TO
severe	JJ
pulmonary	JJ
fibrosis	NN
.	.

Then	RB
the	DT
expression	NN
of	IN
TGF-b1	NN
and	CC
Smad3	NN
increased	VBD
.	.

Activated	VBN
Smad3	NN
bound	VBD
to	TO
the	DT
IL-31	NN
promoter	NN
region	NN
,	,
followed	VBN
by	IN
the	DT
activation	NN
of	IN
JAK-STAT	NN
pathways	NNS
.	.

The	DT
inhibitor	NN
of	IN
TGF-b1	NN
receptor	NN
decreased	VBD
the	DT
IL-31	NN
expression	NN
and	CC
knocking-down	NN
of	IN
IL-31	NN
also	RB
decreased	VBD
the	DT
STAT1	NN
expression	NN
.	.

We	PRP
conclude	VBP
that	IN
there	EX
is	VBZ
a	DT
pathway	NN
of	IN
pathogenesis	NN
in	IN
BLM-induced	JJ
mouse	NN
model	NN
that	WDT
involves	VBZ
the	DT
TGF-b	NN
,	,
IL-31	NN
and	CC
JAKs/STATs	NN
pathway	NN
.	.

